IO BIOTECH INC's ticker is and the CUSIP is 449778109. A total of 20 filers reported holding IO BIOTECH INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,258,818 | -32.4% | 3,640,015 | 0.0% | 0.89% | -8.5% |
| Q1 2024 | $6,297,226 | -8.0% | 3,640,015 | 0.0% | 0.97% | -8.5% |
| Q4 2023 | $6,843,228 | +33.3% | 3,640,015 | 0.0% | 1.06% | -32.2% |
| Q3 2023 | $5,132,421 | +160.3% | 3,640,015 | +261.0% | 1.57% | +354.0% |
| Q2 2023 | $1,971,494 | +4.3% | 1,008,437 | 0.0% | 0.35% | -11.5% |
| Q1 2023 | $1,890,819 | -18.5% | 1,008,437 | 0.0% | 0.39% | -21.6% |
| Q4 2022 | $2,319,405 | -15.1% | 1,008,437 | 0.0% | 0.50% | -21.7% |
| Q3 2022 | $2,733,000 | -42.0% | 1,008,437 | 0.0% | 0.64% | -49.2% |
| Q2 2022 | $4,709,000 | -20.7% | 1,008,437 | -10.0% | 1.26% | -16.1% |
| Q1 2022 | $5,938,000 | -17.2% | 1,120,437 | 0.0% | 1.50% | +7.5% |
| Q4 2021 | $7,171,000 | – | 1,120,437 | – | 1.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,120,437 | $7,171,000 | 1.39% |
| Vivo Capital, LLC | 3,015,545 | $19,299,000 | 1.16% |
| Novo Holdings A/S | 3,277,932 | $20,979,000 | 0.99% |
| Soleus Capital Management, L.P. | 672,734 | $4,305,000 | 0.43% |
| PFM Health Sciences, LP | 1,362,144 | $7,744,000 | 0.26% |
| RA Capital Management | 1,857,755 | $11,890,000 | 0.21% |
| Avoro Capital Advisors LLC | 2,055,883 | $10,243,000 | 0.17% |
| Virtu Financial LLC | 12,665 | $83,000 | 0.01% |
| CAAS CAPITAL MANAGEMENT LP | 50,479 | $323,000 | 0.01% |
| Capital World Investors | 1,235,000 | $8,114,000 | 0.00% |